Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

If the influenza virus infecting cattle workers starts a pandemic, help in the form of a vaccine is months away ...

and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” About ARCT-2304 ARCT-2304 is a sa-mRNA vaccine candidate formulated within ...

Other pharmaceutical companies, such as Moderna and Pfizer, are actively working on developing an mRNA bird flu vaccine using ...

“Arcturus is actively engaged with the U.S. government to prepare for the next pandemic, and clearance to proceed into the clinic with our STARR self-amplifying mRNA ... potential vaccine to protect ...

Hawaii is the only US state that hasn't reported H5N1 avian flu in birds or animals. The state hasn't reported any recent ...

In 2023, Moderna started a phase 1/2 study of an experimental pandemic influenza vaccines collectively known as mRNA-1018, which are designed to provide protection against H5 and H7 avian ...

France raises bird flu risk to high as EU cases increase ... by approving Moderna's RSV vaccine for adults aged 60 and over, ...

SINGAPORE: In a bid to bolster Singapore’s healthcare resilience, the country has launched Asia’s first fully automated mRNA ...